Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome
-
- Seung-Hyun Jung
- Integrated Research Center for Genome Polymorphism, Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Yoo-Jin Kim
- Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Seon-Hee Yim
- Integrated Research Center for Genome Polymorphism, Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Hye-Jung Kim
- Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Yong-Rim Kwon
- Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Eun-Hye Hur
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
-
- Bon-Kwan Goo
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
-
- Yun-Suk Choi
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
-
- Sug Hyung Lee
- Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Yeun-Jun Chung
- Integrated Research Center for Genome Polymorphism, Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea
-
- Je-Hwan Lee
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
収録刊行物
-
- Oncotarget
-
Oncotarget 7 (34), 55264-55275, 2016-07-11
Impact Journals, LLC